Mehmet Özgür YÜCEL, Kadir Turgay AKGÜL, Rüştü Cankon GERMİUANOĞLU, Hesna Müzeyyen ASTARCI, Hüseyin ÜSTÜN, Emre HURİ

The second step in vitro trial of Ankaferd® Bloodstopper®: comparison with other hemostatic agents

To investigate the efficacy of Ankaferd Bloodstopper (ABS) and compare ABS with the other hemostatic agents still used in urologic surgery. Materials and methods: Forty Wistar rats were divided into 5 groups: Group T (traditional), partial nephrectomy (PN) with hilar control as per the conventional technique; Group G (Glubran 2), conventional PN followed by the application of Glubran 2; Group F (FloSeal), FloSeal application to the resected area of the kidney; Group C (Celox), Celox was applied; Group A (ABS), Ankaferd was used. Warm ischemia time (WIT) and hemostasis time (HT) were recorded and histopathologic features were compared among the groups. Results: In Group A, a significant decrease in WIT was detected while the difference was significant (P < 0.001). Statistical analysis confirmed that the evaluation of HT (in seconds) returned similar results to those seen in WITs among all groups. In Group A, decreased HT was confirmed in comparison to Group T while HT increased in comparison to the other groups (G, C, and F) (P < 0.001). Increased fibrosis and adhesion were shown in Group F while significant erythrocyte aggregation and microvascular proliferation were observed in Groups G, F, and A (P < 0.001). Conclusion: A novel hemostatic agent, ABS, is as effective as other licensed hemostatic agents with comparable WIT and HT and better results in terms of histopathologic findings.

Anahtar Kelimeler:

Key words: Hemostatic agents, hemostasis, comparison, partial nephrectomy

The second step in vitro trial of Ankaferd® Bloodstopper®: comparison with other hemostatic agents

Keywords:

Key words: Hemostatic agents, hemostasis, comparison, partial nephrectomy,

PDF

___

Huri E, Akgül T, Ayyıldız A, Üstün H, Germiyanoğlu C. Hemostatic role of a folkloric medicinal plant extract in a rat partial nephrectomy model: controlled experimental trial. J Urol 2009; 181: 2349-54. 2.
Leibovich BC, Blute ML, Cheville JC, Lohse CM., Weaver AL,
Zincke H. Nephron sparing surgery for appropriately selected
renal cell carcinoma between 4 and 7 cm results in outcome
Ogan K, Jacomides L, Saboorian H, Koeneman K, Li Y, Napper C, Hoopman J et al. Sutureless laparoscopic heminephrectomy using laser tissue soldering in the porcine model. J Endourol 2003; 17; 295-300.
Göker H, Haznedaroğlu IC, Erçetin S, Kirazlı S, Akman U, Öztürk Y et al. Haemostatic actions of the folkloric medicinal plant extract Ankaferd BloodStopper ®. J Int Med Res. 2008; 36: 163-70.
Manikandan R, Srinivasan V, Rané A. Which is the real gold standard for small-volume renal tumors? Radical nephrectomy versus nephron-sparing surgery. J Endourol 2004; 18: 39-44.
Bak JB, Singh A, Shekarriz B. Use of gelatin matrix thrombin tissue sealant as an effective hemostatic agent during laparoscopic partial nephrectomy. J Urol 2004; 171: 780-82.
Germiyanoğlu C, Huri E, Akgül T, Ayyıldız A., Üstün H. In vivo haemostatic effect of Ankaferd Blood Stopper® in rat major renal trauma model: controlled trial of novel haemostatic agent. Int J Hematology and Oncology. 2009, in press
Huri E, Akgul T, Ayyildiz A, Germiyanoglu C. Hemostasis in retropubic radical prostatectomy with Ankaferd BloodStopper: a case report. Kaohsiung J Med Sci 2009; 25: 445-47.
Hong YM, Loughlin KR. The use of hemostatic agents and sealants in urology. J Urol 2006; 176: 2367-74.
Gill IS, Ramani AP, Spaliviero M, Xu M., Finelli A, Kaouk JH. Improved hemostasis during laparoscopic partial nephrectomy using gelatin matrix thrombin sealant. Urology 2005; 65: 463- 66.
Dalpiaz O, Neururer R, Bartsch G, Peschel R. Haemostatic sealants in nephron-sparing surgery: what surgeons need to know. BJU Int 2008; 102: 1502-08.
Johnston WK, Hollenbeck BK, Daignault S, Wolf JS Jr. Acute integrity of closure for partial nephrectomy: comparison of 7 agents in a hypertensive porcine model. J Urol 2006; 175: 2307- 11.
Kozen BG, Kircher SJ, Henao J, Godinez FS, Johnson AS. An alternative hemostatic dressing: comparison of CELOX, HemCon, and QuickClot. Acad Emerg Med 2008; 15: 74-81.